Quick answers
- What is Lunsumio Velo?
- Lunsumio Velo is a brand name of Mosunetuzumab, a prescription medicine. The FDA NDC Directory lists 2 Lunsumio Velo products in 2 strengths and forms.
- Who makes Lunsumio Velo?
- Genentech Inc holds the FDA application for Lunsumio Velo (BLA761263, approved December 22, 2022).
- Is there a generic or store brand of Lunsumio Velo?
- Other products of Mosunetuzumab are listed with the FDA, but none in exactly the same strength and form as a Lunsumio Velo product.
- Has Lunsumio Velo been recalled?
- No recall linked to Lunsumio Velo products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Lunsumio Velo is
Each Lunsumio Velo product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Mosunetuzumab · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| mosunetuzumab 45 mg/mL injection (subcutaneous) | Lunsumio Velo | None listed | DailyMed |
| mosunetuzumab 5 mg/0.5 mL injection (subcutaneous) | Lunsumio Velo | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Mosunetuzumab →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761263 | Genentech Inc | December 22, 2022 | 2 |
Companies that list Lunsumio Velo
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Lunsumio Velo products.
- Genentech, Inc.2 products
Recalls
No recall linked to Lunsumio Velo products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.